Search Results

Research Publications
Manuscripts
  • Bailey JE, Barton PL, Lezotte D, Lowenstein SR, Dart RC.  The effect of FDA approval of a generic competitor to OxyContin® (Oxycodone HCl Controlled-Release) tablets on the abuse of oxycodone.  Drug and Alcohol Dependence.  2006;84:182-187.
  • Bailey JE, Campagna E, Dart RC, Reporting for the RADARSīƒĸ System Poison Center Group. The underrecognized toll of prescription opioid abuse on young children. Annals of Emergency Medicine. 2009;53:419-424.
  • Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz A.  The development of a comprehensive risk-management program for prescription opioid analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®).  Pain Medicine. 2007;8(2),157-170.
  • Cicero TJ, Ellis MS, Paradis A, Ortbal Z.  Determinants of Fentanyl and other potent μ opioid agonist misuse in opioid-dependent individuals.  Pharmacoepidemiology and Drug Safety. 2010;19:1-7.
  • Cicero TJ, Ellis MS, Paradis A, Ortbal Z. The role of key informants and direct patient interviews in epidemiological studies of substance abuse. Pharmacoepidemiology and Drug Safety. 2010;In Press.
  • Cicero TJ, Inciardi JA.  Diversion and abuse of methadone prescribed for pain management.  Journal of the American Medical Association.  2005;293(3):297-298.
  • Cicero TJ, Inciardi JA, Munoz A.  Trends of abuse in OxyContin® and other opioid analgesics in the United States: 2002-2004.  The Journal of Pain.  2005;6(10):662-672.
  • Cicero TJ, Inciardi JA, Surratt HL.  Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States.  Drug and Alcohol Dependence.  2007;91:115-120.
  • Cicero T, Inciardi JA, Surratt H, Horbay G, Bordman J, Forster I.  Characteristics of prescription opioid abuse in the United States and Canada.  Canadian Journal of Addiction Medicine. 2010;In Press.
  • Cicero TJ, Surratt H, Inciardi JA, Munoz A.  Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban and urban locations in the United States.  Pharmacoepidemiology and Drug Safety.  2007;16:827-840.
  • Dasgupta N, Bailey JE, Cicero T, Inciardi JA, Parrino M, Rosenblum A, Dart RC. Post-marketing surveillance of methadone and buprenorphine in the United States.  Pain Medicine. 2010;In Press.
  • Hayes BD, Klein-Schwartz W, Doyon S.  Toxicity of buprenorphine overdoses in children.  Pediatrics. 2008;121:782-786.
  • Hughes AA, Bogdan GM, Dart RC, Reporting for the Researched Abuse Diversion and Addiction-Related Surveillance (RADARS®) System Poison Center Group.  Active surveillance of abused and misused prescription opioids using poison center data:  A pilot study and descriptive comparison.  Clinical Toxicology.  2007;45:144-151.
  • Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, Woody GE.  The diversion of Ultram®, Ultracet®, and generic tramadol HCl.  Journal of Addictive Diseases.  2006;25:53-58.
  • Inciardi JA, Goode JL.  OxyContin® and prescription drug abuse.  Consumers’ Research.  2003;(July):17-21.
  • Inciardi JA, Surratt HL, Cicero TJ, Beard RA.  Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment.  Pain Medicine. 2009;10(3):537-548.
  • Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW.  The ‘black box’ of prescription drug diversion.  Journal of Addictive Diseases.  2009;28(4):332-347.
  • Inciardi JA, Surratt HL, Cicero TJ, Rosenblum A, Ahwah C, Bailey JE, Dart RC, Burke JJ.  Prescription drugs purchased through the internet: Who are the end users?  Drug and Alcohol Dependence.  2010; 110(1-2):21-9.
  • Inciardi JA, Surratt HL, Kurtz SP, Burke JJ.  The diversion of prescription drugs by health care workers in Cincinnati, Ohio.  Substance Use and Misuse.  2006;41:255-264.
  • Inciardi JA, Surratt HL, Lugo Y, Cicero TJ.  The diversion of prescription opioid analgesics. Law Enforcement Executive Forum Journal.  2007;(November):125-141.
  • Inciardi JA, Surratt HL, Stivers Y, Cicero TJ.  FDA approvals of generic drugs:  Impact on the diversion of opioid analgesics with a potential for abuse.  Journal of Opioid Management.  2009;5(2) 81-87.
  • Maxwell JC, McCance-Katz EF.  Indicators of buprenorphine and methadone use and abuse: What do we know?  The American Journal on Addictions.  2009;19:73–88.
  • Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland C, Magura S, Haddox D.  Prescription opioid abuse among enrollees into methadone maintenance treatment.  Drug and Alcohol Dependence. 2007; 90:64-71.
  • Schneider, MF, Bailey, JE, Cicero TJ, Dart RC, Inciardi JA, Parrino M, Munoz A.  Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.  Pharmacoepidemiology and Drug Safety. 2009;18(9):778-90.
  • Smith MY, Bailey JE, Woody GE, Kleber HD.  Abuse of buprenorphine in the United States: 2003 – 2005. Journal of Addictive Diseases.  2007;26(3):107–111.
  • Smith MY, Dart RC, Hughes AA, Geller A, Senay EC, Woody GE, Colucci S.  Clinician validation of poison control center intentional exposure cases involving prescription opioids.  American Journal of Drug and Alcohol Abuse.  2006;32:465-478.
  • Smith MY, Irish W, Wang J, Haddox J, Dart RC.  Detecting signals of opioid analgesic abuse: Application of a spatial mixed effect Poisson regression model using data from a network of poison control centers.  Pharmacoepidemiology and Drug Safety.  2008;17:1050-1059.
  • Smith MY, Rosenblum A, Parrino M, Haddox JD, Fong C, Colucci S.  Validity of self-reported misuse of prescription opioid analgesics.  Substance Use and Misuse. 2010;45:1509-1524.
  • Smith MY, Schneider MF, Wentz A, Hughes A, Haddox JD, Dart RC.  Quantifying morbidity associated with the abuse and misuse of opioid analgesics: A comparison of two approaches.  Clinical Toxicology.  2007;456:23-30.
  • Spiller H, Bailey JE, Dart RC, Spiller SS.  Investigation of temporal changes of abuse and misuse of prescription opioids.  Journal of Addictive Disease.  2010;29:78-83.
  • Spiller H, Lorenz DJ, Bailey JE, Dart, RC.  Epidemiological trends in abuse and misuse of prescription opioids.  Journal of Addictive Diseases.  2009;28:130-136.

 

Abstracts
  • Bailey JE, Bogdan GM, Dart RC.  Adolescent prescription opioid abuse and misuse.  The Colorado Public Health Association Conference.  Vail, CO.  August, 2006.
  • Bailey JE, Bogdan GM, Dart RC.  Extended release versus immediate release morphine: Differences in abuse and medical outcomes.  North American Congress of Clinical Toxicology Conference.  San Francisco, CA.  October, 2006.
  • Bailey JE, Bogdan GM, Dart RC, Reporting for the RADARS® System Poison Control Centers.  Demographic differences in the misuse and abuse of oxycodone formulations: Poison center surveillance.  The Drug Information Association Conference.  Philadelphia, PA.  June, 2006.
  • Bailey JE, Dart RC.  Exposures to oxycodone: Demographic differences by formulation.  American College of Emergency Physicians.  New Orleans, LA.  October, 2006.
  • Buchholtz C, Reifler LM, Bailey JE, Dart RC.  Chewing then swallowing in self reported non-medical opioid use by college students as reported by the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System.  The College on Problems of Drug Dependence Annual Meeting.  Scottsdale, AZ.  June, 2010.
  • Buchholtz C, Thomasset C, Bailey JE, Dart RC.  Administration routes involved in non-medical use of long-acting opioids in the RADARS® System College Survey and Poison Center Programs.  North American Congress of Clinical Toxicology Conference. Denver, CO.  October, 2010.
  • Campagna E, Bailey JE, Dart RC.  Prescription opioid abuse in urban versus rural communities using RADARS® System Data.  The College on Problems of Drug Dependence Conference.  Quebec City, Canada.  June, 2007.
  • Campagna E, Bailey JE, Dart RC.  Fentanyl patch abuse using RADARS® System Poison Center Data.  North American
    Congress of Clinical Toxicology Conference.  New Orleans, LA.  October, 2007. 
  • Campagna E, Bailey JE, Dart RC.  Detection of prescription opioid abuse/diversion using RADARS® System Data.  The College on Problems of Drug Dependence Annual Meeting.  San Juan, PR.  June 2008.
  • Campagna E, Kirtland MN, Bailey JE, Spiller HA, Dart RC.  The effectiveness of the Kentucky operation UNITE (Unlawful Narcotics Investigations, Treatment and Education) as evaluated by RADARS® System Poison Centers.  The American Public Health Association Conference.  Washington, DC.  November, 2007.
  • Cleland C, Rosenblum A, Fong C, Parrino M.  Prescription opioid abuse predicts first admission into methadone maintenance treatment.  The College on Problems of Drug Dependence Annual Meeting.  Scottsdale, AZ.  June, 2010.
  • Cleland C, Rosenblum A, Fong C, Parrino M, Magura S.  Age effects on heroin and prescription opioid abuse among enrollees into methadone maintenance treatment.  The College on Problems of Drug Dependence.  Reno, NV.  June, 2009.
  • Cram LM, Bailey JE, Dart RC.  Description of buprenorphine, methadone, hydrocodone and oxycodone abuse and diversion rates using RADARS® System Data.  The College on Problems of Drug Dependence Conference.  Quebec City, Canada.  June, 2007.
  • Dart RC, Hughes AA, Reporting for the RADARS® System Poison Control Centers.  Public health disparities in rural areas: High rates of prescription opioid abuse?  The American Public Health Association Conference.  Philadelphia, PA.  December, 2005.
  • Dart RC, Hughes AA, Smith MY Reporting for the RADARS® System Poison Control Centers.  Adolescent prescription opioid abuse and misuse: Surveillance by Poison Centers.  The College on Problems of Drug Dependence Conference.  Scottsdale, AZ.  June, 2006.
  • Dasgupta N, Bailey JE, Dart RC, Funk MJ.  Poison center intentional exposure calls predict mortality due to prescription opioids.  The American Public Health Association Conference.  Washington, DC.  November, 2007.
  • Davis J, Buchholtz C, Wheat A, Bartelson BB, Dart RC. Predictors of moderate, substantial or severe problems associated with drug abuse in college students reporting recent opioid use. College on Problems of Drug Dependence Annual Meeting. Hollywood, FL. June, 2011.
  • Davis J, Miller H, Winter E, Dart RC. Suicide behaviors with prescription drugs in individuals over 50 years of age identified by Radars System Poison Center Program. American Public Health Association Annual Meeting. Washington, DC. October, 2011.
  • Davis J, Miller H, Winter E, Dart RC. Suicide behaviors with prescription drugs in individuals over 50 years of age identified by Radars System Poison Center Program. American Public Health Association Annual Meeting. Washington, DC. October, 2011.
  • Graham A, Smith MY, Haddox JD, Wright C.  Reducing the potential for diversion of prescription opioids: Tested interventions.  The College on Problems of Drug Dependence Conference.  Orlando, FL.  June, 2005.
  • Green JL, Dart RC, Bartelson BB. Buprenorphine abuse in the United States: Comparison to methadone using five surveillance programs simultaneously. European Association of Poisons Centres and Clinical Toxicologists. Dubrovnik, Croatia. May, 2011.
  • Haddox JD, Schnoll SH.  The standards for risk management plans for high abuse potential medications.  The College on Problems of Drug Dependence Conference.  Washington, DC.  April, 2005.
  • Haddox JD, Smith MY, Colucci S, Rosenblum A, Fong C, Maxwell C, Parrino M.  Pain as a reason for seeking admission to methadone treatment.  The College on Problems of Drug Dependence Conference.  Scottsdale, AZ.  June, 2006.
  • Hedge MW, Smolinski S, Bailey JE, Dart RC, RADARS System Poison Center Group.  Ototoxicity of prescription opioids. North American Congress of Clinical Toxicology Conference.  San Antonio, TX.  September, 2009.
  • Hughes AA, Bogdan GM, Bond R, Dart RC.  Increase in OxyContin® abuse or media hype?  North American Congress of Clinical Toxicology Conference.  Palm Springs, CA.  September, 2002. 
  • Hughes AA, Bogdan GM, Dart RC.  Comparative rates of OxyContin® abuse: Anecdotal highs.  North American Congress of Clinical Toxicology Conference.  Chicago, IL.  September, 2003.
  • Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers.  Demographic differences of the misuse and abuse of oxycodone formulations.  The Colorado Public Health Association Conference.  Denver, CO.  September, 2005.
  • Hughes AA, Dart RC, Bailey JE, Reporting for the RADARS® System Poison Control Centers.  Lick or stick: The common routes of the misuse and abuse of fentanyl.  North American Congress of Clinical Toxicology Conference.  Orlando, FL.  September, 2005.
  • Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers.  Prescription drug abuse epidemic: Surveillance of opioid abuse using poison centers.  The American Public Health Association Conference.  Philadelphia, PA.  December, 2005.
  • Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers.  Seasons of abuse?  Temporal trends of prescription opioids.  North American Congress of Clinical Toxicology Conference.  Seattle, WA.  September, 2004.
  • Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers.  Surveillance of the RADARS® System by poison control centers.  The College on Problems of Drug Dependence Conference.  Orlando, FL.  June, 2005.
  • Inciardi JA, Surratt HL.  The diversion of prescription opioids in the US.  The College on Problems of Drug Dependence Conference.  Scottsdale, AZ.  June, 2006.
  • Inciardi JA, Surratt H, Kurtz SP, Cicero TJ.  The diversion of generic prescription drugs.  The College on Problems of Drug Dependence Conference.  Quebec City, Canada.  June, 2007.
  • Kirtland MN, Bailey JE, Dart RC.  Prescription opioid misuse and abuse:  Surveillance by the RADARS® System Poison Centers.  American Pain Society.  Washington, DC.  May, 2007.
  • Kirtland MN, Bailey JE, Dart RC.  Suicide and gender: Characterization using RADARS® System Poison Center Data.  American Psychiatric Association.  Washington, DC.  May, 2008.
  • Kirtland MN, Bailey JE, Dart RC.  Prescription opioid associated death rates using RADARS® System Data.  American Academy of Addiction Psychiatry Conference.  Boca Raton, FL.  December, 2008.
  • Kirtland MN, Lemon S, Bailey JE, Dart RC.  Effectiveness of a poison center intervention on product coding.  North American Congress of Clinical Toxicology Conference.  Toronto, Canada.  September, 2008.
  • Kline AT, Smith MY, Fitzgerald JP, Haddox JD, Bailey JE.  A comparison of NSDUH results and RADARS® System Poison Center Network results for the non-medical use of opioid analgesics, 2003-2004.  The College on Problems of Drug Dependence Conference.  Quebec City, Canada.  June, 2007.
  • Kline AT, Smith MY, Haddox JD, Rosenblum A, Fong C, Parrino, M, Maxwell C.  Abuser-reported sources of illegally obtained opioid analgesic medications.  The College on Problems of Drug Dependence Conference.  Scottsdale, AZ.  June, 2006.
  • Kurtz SP, Surratt HL, Cicero TJ, Ibanez GE, Rosenblum A, Dart RC, Inciardi JA. Internet-based diversion of prescription opioids. American Academy of Pain Medicine Annual Meeting. Washington, DC. March 2011.
  • Lindholm A, Varughese S, Rosen S, Sembower M, Ertischek M, St. Jean E, Schnoll S.  Innovative use of multiple surveillance data sources for detection of misuse, abuse and diversion in the Risk Management Plan (RMP) of stimulant medications used in ADHD.  Drug Information Association 2009 Annual Meeting.  San Diego, CA.  June, 2009.
  • Montoya AM, Bailey JE, Dart RC.  Current nonmedical prescription drug use among college students: Analysis of RADARS® System Data.  The American Academy of Addiction Psychiatry Conference.  Boca Raton, FL.  December, 2008.
    Montoya AM, Heltshe SL, Dart RC.  Spatial analysis of RADARS® System Data to identify geographic hot spots of prescription opioid abuse.  The College on Problems of Drug Dependence Conference.  San Juan, PR.  June, 2008.
  • Montoya AM, Zolot LM, Bailey JE, Dart RC.  Motives for non-medical prescription opioid use among RADARS® System College Survey respondents–Indication of a substance abuse disorder?  The College on Problems of Drug Dependence Annual Meeting.  Reno, NV.  June, 2009.
  • Parrino M, Rosenblum A, Fong C, Maxwell C, Magura S.  Distance traveled and cross state commuting among patients in Opioid Agonist Treatment Programs (OTPs).  The College on Problems of Drug Dependence Annual Meeting.  San Juan, PR.  June, 2008.
  • Reifler LM, Droz D, Bartelson BB, Bailey JE, Dart RC.  RADARS® System Poison Center opioid abuse and misuse rates over time in states with and without active prescription monitoring programs.  American Public Health Association Annual Meeting.  Denver, CO.  November, 2010.
  • Reifler LM, Droz D, Bartelson BB, Bailey JE, Schnoll, Dart RC, RADARS System Poison Center Group.  Reduction over time in RADARS® System Poison Center opioid abuse/misuse rates associated with prescription monitoring programs.  North American Congress of Clinical Toxicology Conference.  Denver, CO.  October, 2010.
  • Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Haddox JD, Magura S.  Prescription opioid abuse among patients enrolling in methadone maintenance treatment.  The College on Problems of Drug Dependence Conference.  Quebec City, Canada.  June, 2007.
  • Schnoll SH, Sembower MA, Shiffman S, Varughese S, Ertischek MD, St. Jean E, Rosen S.  Non-medical use of extended release prescription stimulants: An examination of amphetamine and methylphenidate.  The College on Problems of Drug Dependence Annual Meeting.  Scottsdale, AZ.  June, 2010.
  • Senay EC, Geller A, Woody G, Dart RC, Hughes A, Smith MY.  Patterns of abuse, dependence and misuse of prescription opioid analgesics, benzodiazepines and carisoprodol in 7792 calls to poison control centers.  The College on Problems of Drug Dependence Conference.  Orlando, FL.  June, 2005.
  • Smith MY, Dart RC, Hughes A, Geller A, Senay EC, Woody G, Colucci S.  Clinician validation of poison control center intentional exposure cases involving prescription opioids.  The College on Problems of Drug Dependence Conference.  Orlando, FL.  June, 2005.
  • Smith MY.  Measuring rates of nonmedical use - Dimensions and denominators.  The College on Problems of Drug Dependence Conference.  Washington, DC.  April, 2005.
  • Smith MY, Irish W, Wang J, Haddox JD, Dart RC.  Relative rate of opioid analgesic abuse in communities in the US.  The College on Problems of Drug Dependence Conference.  Scottsdale, AZ.  June, 2006.
  • Spaeth AL, Bailey JE, Dart RC.  Characterization of buprenorphine abuse using RADARS® System Poison Center Data.  The College on Problems of Drug Dependence Annual Meeting.  San Juan, PR.  June, 2008.
  • Spiller HA, Lorenz D, Bailey JE, Dart RC.  Epidemiological trends in prescription drug misuse and abuse.  The College on Problems of Drug Dependence Annual Meeting.  San Juan, PR.  June, 2008.
  • Spiller HA, Spiller SS, Bailey JE, Dart RC.  Does day of week impact prevalence of prescription drug abuse?  The College on Problems of Drug Dependence Annual Meeting.  Reno, NV.  June, 2009.
  • Spiller HA, Spiller SS, Bailey JE, Dart RC.  Does prescription drug abuse take a holiday?  The College on Problems of Drug Dependence Annual Meeting.  Reno, NV.  June, 2009.
  • Sweet LE, Zolot L, Bailey JE, Dart RC.  Where do calls come from? Analysis of RADARS® System Opioid and Stimulant Poison Center (PC) mentions by caller site and intent.  North American Congress of Clinical Toxicology Conference.  San Antonio, TX.  September, 2009.
  • Varney SM, Buchanan JA, Lavonas EJ, Campagna EJ, Bailey JE, Dart RC.  How opioid-acetaminophen patients die.  North American Congress of Clinical Toxicology Conference.  Toronto, Canada.  September, 2008.
  • Varughese S, Rosen S, Ertischek MD, Sembower MA, St. Jean E, Schnoll S.  Non-medical use surveillance and signal identification of Lisdexamfetamine Dimesylate, a pro-drug stimulant for the treatment of ADHD.  American Psychiatric Association Annual Meeting.  New Orleans, LA.  May, 2010.
  • Varughese S, Rosen S, Lindholm A, Ertischek MD, Sembower MA, Schnoll S. Non-medical use surveillance and signal identification of lisdexamfetamine dimesylate, a pro-drug stimulant for the treatment of ADHD. American Academy of Child and Adolescent Psychiatry Annual Meeting. New York, NY. October, 2010.
  • Varughese S, Rosen S, Lindholm A, Ertischek MD, Sembower MA, St. Jean E, Schnoll S.  Non-medical use surveillance and signal identification of lisdexamfetamine dimesylate, a pro-drug stimulant for the treatment of ADHD.  Canadian Psychiatric Association.  Toronto, Canada.  September, 2010.
  • Zosel AE, Campagna E, Bailey JE, Dart RC.  Demographic variables associated with prescription opioid abuse and diversion detected by the RADARS® System.  The College on Problems of Drug Dependence Annual Meeting.  San Juan, PR.  June 2008.
  • Wheat A, Buchholtz C, Davis J, Dart RC. Predictors of severe prescription drug abuse among college students using the RADARS System College Survey. College on Problems of Drug Dependence Annual Meeting. Hollywood, FL. June, 2011.
  • Wheat A, Davis J, Bartelson BB, Buchholtz C, Dart RC. Is drug source a predictor of severity of non-medical prescription drug use among college students? Do source predictors vary by Gender? American Public Health Association Annual Meeting. Washington, DC. October, 2011.
  • Wheat A, Davis J, Bartelson BB, Dart RC. The interaction between gender and severity of prescription drug abuse among college students on ability to correctly identify photos of recently abused drugs. International Conference of Pharmacoepidemiology. Chicago, IL. August, 2011.
  • Winter EJ, Buchholtz C, Davis JM, Severtson SG, Dart RC. Poison center calls for intentional exposures to opioids are highly correlated with retail availability in the RADARS System Poison Center Program. North American Congress of Clinical Toxicology Conference. Washington, DC. September 2011.
  • Zosel A, Bailey JE, Buchholtz C, Ross E, Dart RC.  Methadone-associated deaths by formulation as reported by the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System.  The College on Problems of Drug Dependence Annual Meeting.  Scottsdale, AZ.  June, 2010.
  • Zosel AE, Kirtland M, Bailey JE, Dart RC.  Characterization of adolescent prescription drug abuse as reported in RADARS® System Poison Center Data.  The College on Problems of Drug Dependence Annual Meeting.  Reno, NV  June, 2009.

Book Chapters
  • Niemi J, Smith M, Banks D. Biosurveillance and Biosecurity: Lecture Notes in Bioinformatics.  Ed. D Zeng, H Chen, H - Rolka, and W Lober. New York:  Springer, 2008.  131-142.